Abdominal Pain Clinical Trial
Official title:
Physiological Effects of Probiotic Bacteria Lactobacillus Acidophilus NCFM Alone Versus a Combination With Bifidobacterium Lactids - LBi07 in Patients With Mild to Moderate Abdominal Pain/Discomfort and Bloating
We are conducting a study to learn if probiotics, which are live bacteria found in food like yogurt and cheese, will improve symptoms of abdominal pain. Individuals participating in this study will take probiotic pills to see if this affects the expression of certain pain receptors in the intestines that relate to pain sensation. Biopsies will be taken from the colon before subjects take the probiotic pills. Subjects will then be given one of two different types of probiotic pills to take for 3-4 weeks. After taking the supplements, more biopsies will be collected to see if any changes have taken places. This study requires one screening visit and two clinic visits to UNC hospital. Subjects will also complete daily diary cards for 2 weeks during the study to record their symptoms and also collect 2 stool samples.
The purpose of this study is to determine if probiotic bacteria, specifically Lactobacillus
and Bifidobacterium, have an effect on pain receptors in the colon. Data from animal studies
suggest that daily consumption of probiotic bacteria can increase expression of specific
receptors in the intestinal mucosa in mice and that these mucosal effects are associated
with decrease in intestinal pain sensation. We are interested to see if this is true in
humans as well.
Probiotics are live bacteria, which can be found in certain foods like yogurt or cheese
prepared with active cultures. The use of probiotics has been shown to be successful in
several intestinal disorders, including chronic inflammatory bowel disease (IBD), childhood
diarrhea (rotavirus infection), and travelers' diarrhea. This has led to increased interest
in their use in patients with symptoms of abdominal pain or discomfort. Although, the data
on the use of probiotics in bloating is limited, several reported studies show encouraging
results and suggest a symptomatic response and parallel improvement in quality of life.
Probiotics are regarded by the US Food and Drug Administration (FDA) as dietary supplements.
They do not require approval by the FDA or any government agency prior to marketing however
they are subjected to the FDA jurisdiction regarding their safety, labeling, and health
statements. Probiotics can be provided in various forms including food (such as yogurt) or
in the format of pills, tablets, caps, and liquids. In this study they will be given in a
pill form.
You are being asked to participate in this study because you are currently experiencing
abdominal pain or discomfort in your abdomen and you have a functional bowel disorder. In
order to determine if these probiotics have an effect, you will be asked to either take a
Bifidobacterium probiotic or a blend of Bifidobacterium plus Lactobacillus probiotic. You
will be asked to undergo an un-prepped, un-sedated flexible sigmoidoscopy both before your
treatment course and after your treatment course. Biopsy samples will be taken during this
procedure to analyze certain pain receptor levels, comparing differences between the two
treatments of probiotics, and differences in receptors before after treatment. We may use
this data for future research in understanding the probiotic function in the gut. We may
also perform genetic testing on these specimens in order to look for relationships between
genes, the environment, and people's habits or diet, and different diseases. All remaining
samples will be stored for-as-yet-unknown tests.
Please note that in order to participate in this study the separate storage consent form is
non-optional and must be signed allowing long term storage of stool samples.
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Basic Science
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04682860 -
Management of Abdominal Pain in Acute Gastroenteritis Patients With Hyoscine Butylbromide
|
Phase 4 | |
Not yet recruiting |
NCT05649891 -
Checklists Resuscitation Emergency Department
|
N/A | |
Completed |
NCT02923245 -
POCUS Assessment of Bladder Fullness for Girls Awaiting Radiology-Performed Transabdominal Pelvic Ultrasound
|
N/A | |
Completed |
NCT03318614 -
Bifidobacterium Infantis M-63 Improves Mental Health in Irritable Bowel Syndrome Developed After a Major Flood Disaster
|
Phase 2/Phase 3 | |
Completed |
NCT02547857 -
Transvaginal Pelvic Ultrasound in the ED
|
N/A | |
Completed |
NCT02676232 -
DARWeb: an Online Psychosocial Intervention for Children With Recurrent Abdominal Pain and Their Families.
|
N/A | |
Completed |
NCT02197780 -
Head-to-head Comparison of Two Fecal Biomarkers to Screen Children for IBD
|
N/A | |
Recruiting |
NCT00209807 -
Effect of Escitalopram vs. Reboxetine on Gastro-intestinal Sensitivity of Patients With Major Depressive Disorder
|
Phase 4 | |
Terminated |
NCT01410071 -
Evaluation of Gastrointestinal Symptoms and Quality of Life in Patients With Sphincter of Oddi Dysfunction
|
N/A | |
Terminated |
NCT01736280 -
Evaluating and Treating Potential Research Participants With Digestive Disorders
|
N/A | |
Enrolling by invitation |
NCT04104867 -
Effectiveness of Prokinetic Agents in Improving Abdominal Discomfort at Colonoscopy
|
N/A | |
Completed |
NCT03574727 -
Abdominal Cutaneous Nerve Entrapment Syndrome
|
||
Completed |
NCT04614649 -
Right Iliac Fossa Treatment-Turkey Audit
|
||
Completed |
NCT05438654 -
Improvement of Diagnostic Approach Using PoCUS for Right Upper Quadrant Abdominal Pain
|
N/A | |
Completed |
NCT06423586 -
Effect of Lecithin-based Curcuma and Boswellia on Post-acute COVID-19 IBS
|
N/A | |
Completed |
NCT03558009 -
Epidemiological Analysis for Hereditary Angioedema Disease
|
||
Terminated |
NCT03148288 -
Vitamin D Supplementation in IBS
|
N/A | |
Completed |
NCT03708874 -
Pain Management of Emergency Laparoscopic Cholecystectomy in Patients With Acute Cholecystitis
|
||
Withdrawn |
NCT04408872 -
EUS vs EGD in Emergency Room Patients Referred for EGD
|
N/A | |
Recruiting |
NCT02594774 -
Efficacy of Osteopathic Treatment in Function Abdominal Pain in Children and Adolescents
|
N/A |